Medical technology company Redsense Medical's CEO Sebastien Bollue bought 15 075 shares in the company on 9 September. The shares were purchased at a price of 2.59 kronor per share, in a transaction worth 39 000 kronor. The transaction was made on Spotlight Stock Market. This is shown by the Swedish Financial Supervisory Authority's insider register.Bollue owned 63 000 shares in Redsense on 26 June, according to the Holdings ownership service.